AVAlba Vidal-Torres

Alba Vidal-Torres

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alba Vidal-Torres has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of road roughness and its influence on operating parameters in open-pit mines

    by Pedro Silva, Hernani Lima, Vidal Torres, Leandro Silveira, Felipe Souza

    Hauling ore and waste rock is a major cost factor in open-pit mines, encompassing both road maintenance and off-road truck operation. Road maintenance costs are directly influenced by traffic volume and the size of trucks using the roads. Off-road truck operating costs are impacted by various factors, including those affecting their movement, such as the direct interaction between tires and the road surface. Tire-road interaction significantly affects rolling resistance. Rougher surfaces with deeper grooves caused by track sinks lead to higher rolling resistance. This study employed laser profiling to characterize the surface roughness of five mine haul roads in two large Brazilian iron ore mines. This study evaluated the impact of these road irregularities on various operating parameters for 240-ton off-highway trucks, including rolling resistance, average travel speed, travel time, productivity, and unit transport cost. The results indicate that a 10 cm increase in road surface roughness can lead to a significant increase in rolling resistance (up to 5%), a substantial decrease in average speed (25%), a notable increase in travel time (26%), a decrease in productivity (19%), and a corresponding increase in unit transport cost (21%).


  • Open Access

    Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids

    by Alba Vidal-Torres, Begoña Fernández-Pastor, Mónica García, Eva Ayet, Anna Cabot, Javier Burgueño, Xavier Monroy, Bertrand Aubel, Xavier Codony, Luz Romero, et al.


  • Open Access

    Supraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception

    by Alba Vidal-Torres, Begoña Fernández-Pastor, Alicia Carceller, José Miguel Vela, Manuel Merlos, Daniel Zamanillo

    Sigma-1 receptor (σ1R) antagonism increases the effects of morphine on acute nociceptive pain. S1RA (E-52862) is a selective σ1R antagonist widely used to study the role of σ1Rs. S1RA alone exerted antinociceptive effect in the formalin test in rats and increased noradrenaline levels in the spinal cord, thus accounting for its antinociceptive effect. Conversely, while systemic S1RA failed to elicit antinociceptive effect by itself in the tail-flick test in mice, it did potentiate the antinociceptive effect of opioids in this acute pain model. The present study aimed to investigate the site of action and the involvement of spinal noradrenaline on the potentiation of opioid antinociception by S1RA on acute thermal nociception using the tail-flick test in rats. Local administration was performed after intrathecal catheterization or intracerebroventricular and rostroventral medullar (RVM) cannulae implantation. Noradrenaline levels in the spinal cord were evaluated using the concentric microdialysis technique in awake, freely-moving rats. Systemic or supraspinal administration of S1RA alone, while having no effect on antinociception, enhanced the effect of morphine in rats. However, spinal S1RA administration did not potentiate the antinociceptive effect of morphine. Additionally, the peripherally restricted opioid agonist loperamide was devoid of antinociceptive effect but produced antinociception when combined with S1RA. Neurochemical studies revealed that noradrenaline levels in the dorsal horn of the spinal cord were not increased at doses exerting potentiation of the antinociceptive effect of the opioid. In conclusion, the site of action of σ1R for opioid modulation on acute thermal nociception is located at the peripheral and supraspinal levels, and the opioid-potentiating effect is independent of the spinal noradrenaline increase produced by S1RA.


  • Effects of the selective sigma‐1 receptor antagonist S1RAon formalin‐induced pain behavior and neurotransmitter release in the spinal cord in rats

    by Alba Vidal‐Torres, Begoña Fernández‐Pastor, Alicia Carceller, José Miguel Vela, Manuel Merlos, Daniel Zamanillo

    We have previously shown that the selective sigma‐1 receptor (σ1R) antagonist S1RA(E‐52862) inhibits neuropathic pain and activity‐induced spinal sensitization in various pre‐clinical pain models. In this study we characterized both the behavioral and the spinal neurochemical effects of S1RAin the rat formalin test. Systemic administration of S1RAproduced a dose‐related attenuation of flinching and lifting/licking behaviors in the formalin test. Neurochemical studies using concentric microdialysis in the ipsilateral dorsal horn of awake, freely moving rats revealed that the systemic S1RA‐induced antinociceptive effect occurs concomitantly with an enhancement of noradrenaline levels and an attenuation of formalin‐evoked glutamate release in the spinal dorsal horn. Intrathecal pre‐treatment with idazoxan prevented the systemic S1RAantinociceptive effect, suggesting that the S1RAantinociception depends on the activation of spinal α2‐adrenoceptors which, in turn, could induce an inhibition of formalin‐evoked glutamate release. When administered locally, intrathecal S1RAinhibited only the flinching behavior, whereas intracerebroventricularly or intraplantarly injected also attenuated the lifting/licking behavior. These results suggest that S1RAsupraspinally activates the descending noradrenergic pain inhibitory system, which may explain part of its antinociceptive properties in the formalin test; however, effects at other central and peripheral sites also account for the overall effect. image Formalin‐induced nociceptive effect occurs concomitantly with an enhancement of glutamate (Glu) level in the dorsal horn spinal cord. The selective σ1 receptor antagonist S1RA results in inhibition of formalin‐evoked Glu release, no modification of GABA levels, and enhancement of noradrenaline (NA) levels. This increased spinal NA activates spinal α2‐adrenoceptors producing the attenuation of the formalin‐induced pain behaviour


  • Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects

    by Alba Vidal-Torres, Beatriz de la Puente, Maria Rocasalbas, Clara Touriño, Simona Andreea Bura, Begoña Fernández-Pastor, Luz Romero, Xavier Codony, Daniel Zamanillo, Helmut Buschmann, et al.


  • Evaluation of Formalin-Induced Pain Behavior and Glutamate Release in the Spinal Dorsal Horn Using In Vivo Microdialysis in Conscious Rats

    by Alba Vidal-Torres, Alicia Carceller, Daniel Zamanillo, Manuel Merlos, José Miguel Vela, Begoña Fernández-Pastor

    Measurement of neurotransmitters in the spinal dorsal horn in conscious animals remains a technical challenge. Here we applied concentric microdialysis to measure formalin-induced glutamate (Glu) release in the ipsilateral dorsal horn in conscious, freely-moving rats. Hind paw formalin injection induced flinching nociceptive behaviors accompanied by increased Glu in the dorsal horn (maximum = 294%). Both flinching and Glu increase were prevented by morphine (3 mg/kg, s.c.). Accordingly, concentric microdialysis is a sensitive technique for studying neurochemical modulation induced by pain and analgesics in the spinal dorsal horn of awake rats. Measurement of Glu provides information on modulation of excitatory signals.